| Hepatic resection versus transplantation for hepatocellular carcinoma. S Iwatsuki, TE Starzl, DG Sheahan, I Yokoyama, AJ Demetris, S Todo, ... Annals of surgery 214 (3), 221, 1991 | 770 | 1991 |
| Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis LM Kulik, BI Carr, MF Mulcahy, RJ Lewandowski, B Atassi, RK Ryu, ... Hepatology 47 (1), 71-81, 2008 | 706 | 2008 |
| p53 mutation in hepatocellular carcinoma after aflatoxin exposure B Bressac, A Puisieux, M Kew, M Volkmann, S Bozcall, JB Mura, ... The Lancet 338 (8779), 1356-1359, 1991 | 632 | 1991 |
| Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. RL Baron, JH Oliver 3rd, GD Dodd 3rd, M Nalesnik, BL Holbert, B Carr Radiology 199 (2), 505-511, 1996 | 498 | 1996 |
| Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type β transforming growth factor BI Carr, I Hayashi, EL Branum, HL Moses Cancer research 46 (5), 2330-2334, 1986 | 392 | 1986 |
| Yttrium-90 microspheres for the treatment of hepatocellular carcinoma JFH Geschwind, R Salem, BI Carr, MC Soulen, KG Thurston, KA Goin, ... Gastroenterology 127 (5), S194-S205, 2004 | 368 | 2004 |
| Hepatocellular carcinoma: current management and future trends BI Carr Gastroenterology 127 (5), S218-S224, 2004 | 308 | 2004 |
| Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: Interim safety and survival data on 65 patients BI Carr Liver Transplantation 10 (S2), S107-S110, 2004 | 301 | 2004 |
| The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma DJ Pinato, R Sharma, E Allara, C Yen, T Arizumi, K Kubota, D Bettinger, ... Journal of hepatology 66 (2), 338-346, 2017 | 294 | 2017 |
| Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation I Yokoyama, B Carr, H Saitsu, S Iwatsuki, TE Starzl Cancer 68 (10), 2095-2100, 1991 | 283 | 1991 |
| Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal … JH Doroshow, P Multhauf, L Leong, K Margolin, T Litchfield, S Akman, ... Journal of Clinical Oncology 8 (3), 491-501, 1990 | 270 | 1990 |
| Yttrium-90 microspheres: radiation therapy for unresectable liver cancer R Salem, KG Thurston, BI Carr, JE Goin, JFH Geschwind Journal of vascular and interventional radiology 13 (9), S223-S229, 2002 | 265 | 2002 |
| Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system S Iwatsuki, I Dvorchik, JW Marsh, JR Madariaga, B Carr, JJ Fung, ... Journal of the American College of Surgeons 191 (4), 389-394, 2000 | 263 | 2000 |
| Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities JE Goin, R Salem, BI Carr, JE Dancey, MC Soulen, JFH Geschwind, ... Journal of Vascular and Interventional Radiology 16 (2), 205-213, 2005 | 262* | 2005 |
| Growth inhibition of hepatoma cells induced by vitamin K and its analogs Y Nishikawa, BI Carr, M Wang, S Kar, F Finn, P Dowd, ZB Zheng, J Kerns, ... Journal of Biological Chemistry 270 (47), 28304-28310, 1995 | 250 | 1995 |
| Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA. M Inagaki, A Moustakas, HY Lin, HF Lodish, BI Carr Proceedings of the National Academy of Sciences 90 (11), 5359-5363, 1993 | 249 | 1993 |
| The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study JW Marsh, I Dvorchik, M Subotin, V Balan, J Rakela, EP Popechitelev, ... Hepatology 26 (2), 444-450, 1997 | 244 | 1997 |
| Heparin-binding growth factor type 1 (acidic fibroblast growth factor): a potential biphasic autocrine and paracrine regulator of hepatocyte regeneration. M Kan, JS Huang, PE Mansson, H Yasumitsu, B Carr, WL McKeehan Proceedings of the National Academy of Sciences 86 (19), 7432-7436, 1989 | 238 | 1989 |
| Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two‐cohort study BI Carr, V Kondragunta, SC Buch, RA Branch Cancer: Interdisciplinary International Journal of the American Cancer …, 2010 | 219 | 2010 |
| Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence JD Reyes, B Carr, I Dvorchik, S Kocoshis, R Jaffe, D Gerber, ... The Journal of pediatrics 136 (6), 795-804, 2000 | 195 | 2000 |
